Menu Search
Equities

Shanghai Fosun Pharmaceutical Group Co Ltd

08HH:FRA

Shanghai Fosun Pharmaceutical Group Co Ltd

Actions
  • Price (EUR)1.45
  • Today's Change-0.021 / -1.43%
  • Shares traded21.00
  • 1 Year change-41.85%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 07:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The Company is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.

  • Revenue in HKD (TTM)44.51bn
  • Net income in HKD2.59bn
  • Incorporated1995
  • Employees40.37k
  • Location
    Shanghai Fosun Pharmaceutical Group Co LtdBuilding A, No. 1289 Yishan RoadSHANGHAI 200233ChinaCHN
  • Phone+86 2 133987870
  • Fax+86 2 133987871
  • Websitehttps://www.fosunpharma.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		600196:SHH since
announced		Transaction
value
Shanghai Rehabilitation Equity Investment Fund Management Co LtdDeal completed30 Oct 202330 Oct 2023Deal completed-18.91%3.04m
Suzhou Xingchen Venture Capital Partnership LPAnnounced22 Jul 202322 Jul 2023Announced-25.83%412.00k
Shining Star (Tianjin) Investment Management Partnership LPAnnounced22 Jul 202322 Jul 2023Announced-25.83%206.00k
Data delayed at least 15 minutes, as of Apr 18 2024 08:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.